Fig. 9From: Exploration for novel inhibitors showing back-to-front approach against VEGFR-2 kinase domain (4AG8) employing molecular docking mechanism and molecular dynamics simulationsMapping of the Hit compound to all the features of the pharmacophore. The compound is found to be well aligned with all the pharmacophore featuresBack to article page